WORLD ANTI-DOPING CODE PROHIBITED LIST
3 Introduction The Prohibited List is a mandatory International Standard as part of the World Anti-Doping Program. The List is updated annually following an extensive consultation process facilitated by WADA.The effective date of the List is 01 January 2021. The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French.
Download WORLD ANTI-DOPING CODE PROHIBITED LIST
Information
Domain:
Source:
Link to this page:
Documents from same domain
MINUTES - WADA FINANCE AND ADMINISTRATION …
www.wada-ama.org1 / 3 MINUTES - WADA FINANCE AND ADMINISTRATION COMMITTEE MEETING HELD IN LAUSANNE ON 22 AUGUST 2007 PRESENT: Craig Reedie, Chairman Patrick Chamunda Robert De …
SUMMARY OF MAJOR MODIFICATIONS AND EXPLANATORY …
www.wada-ama.org3 Substances Prohibited in Particular Sports BETA-BLOCKERS • Bunolol is a racemic mixture of levobunolol and bunolol, so levobunolol was removed as an example in P1.
WORLD ANTI-DOPING CODE - wada-ama.org
www.wada-ama.orgWorld Anti-Doping Code The World Anti-Doping Code was first adopted in 2003, took effect in 2004, and was then amended effective 1 January 2009.
PROHIBITED LIST - World Anti-Doping Agency
www.wada-ama.orgTHE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2018 The official text of the Prohibited List shall be maintained by WADA and shall be published in …
World Anti-Doping
www.wada-ama.orgJan 24, 2012 · PART ONE DOPING CONTROL ... 14.2 NOTICE OF ANTI-DOPING RULE VIOLATION OR ... that robust rules and sanctions are in place and salient for all stakeholders. Detection — an effective Testing and investigations system not only enhances a deterrent effect, but also is effective in
83 - World Anti-Doping Agency
www.wada-ama.orgISTI – January 2021 Page 2 of 83. International Standard for Testing and Investigations . The World Anti-Doping Code International Standard for Testing and Investigations is a mandatory International Standard developed as part of the World Anti -Doping Program. It was developed in consultation with Signatories, public authorities, and other relevant stakeholders.
1 of 56
www.wada-ama.orgPART ONE: INTRODUCTION, CODE PROVISIONS, INTERNATIONAL STANDARD PROVISIONS AND DEFINITIONS 1.0 Introduction and Scope The International Standardfor Results Management is a mandatory International Standard developed as part of the World Anti -Doping Program. The purpose of the International Standardfor Results Management is to set …
WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD …
www.wada-ama.org• Vascular endothelial growth factor (VEGF) and other growth factors or growth factor modulators affecting muscle, tendon or ligament protein synthesis/degradation, vascularisation, energy utilization, regenerative capacity or fibre type switching. 3. GROWTH FACTORS AND GROWTH FACTOR MODULATORS S2 PEPTIDE HORMONES, GROWTH FACTORS, …
WORLD ANTI-DOPING CODE
www.wada-ama.orgInternational Standards International Standards for different technical and operational areas within the anti-doping program have been and will be developed in consultation with the Signatories and governments and approved by WADA. The purpose of the International Standards is harmonization among Anti-Doping Organizations responsible for
PROHIBITED LIST - World Anti-Doping Agency
www.wada-ama.org2 in accordance with article 4.2.2 of the world anti-doping code, all prohibited substances shall be considered as “specified substances” except substances in classes s1, s2, s4.4, s4.5, s6.a, and prohibited methods m1, m2 and m3. prohibited substances substances & methods
Related documents
Antidiabetic Medication Comparison Chart - South Dakota
dhs.sd.govDopamine Agonists Bromocriptine (Cycloset) 0.1 Neutral Neutral Neutral Moderate Neutral Neutral Neutral Hypotension Unknown Unknown 200 Expected A1c lowering based on monotherapy Adapted from AACE Comprehensive Diabetes Management Algorithm/Lex-Drug Antidiabetic Agents Comparison Tables ^ Generic available
What is opioid agonist therapy? Opioid agonist therapy
www.camh.catherapy involves taking the opioid agonists methadone (Methadose) or buprenorphine (Suboxone). These medications work to prevent withdrawal and reduce cravings for opioid drugs. People who are addicted to opioid drugs can take OAT to help stabilize their lives and to reduce the harms related to their drug use. How does opioid agonist therapy work?
BUPRENORPHINE (Trade Names: Buprenex®, Suboxone®, …
www.deadiversion.usdoj.govagonists (e.g., e.g., morphine) and partial agonists (pentazocine) depending on dose, pattern of use, and population taking the drug. It is about 20times more potent than -30 morphine as an analgesic; and like morphine it produces dose-related euphoria, drug liking, constriction, respiratory papillary depression and sedation.
GLI-2012 All-Age Multi-Ethnic Reference Values for …
www.ers-education.orgGLI2012 reference values for spirometry 2 Interpretation of spirometric data Philip H. Quanjer Sanja Stanojevic Janet Stocks Tim J. Cole Introduction